Format

Send to

Choose Destination
See comment in PubMed Commons below
Elife. 2015 Sep 1;4. doi: 10.7554/eLife.08467.

Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome.

Author information

  • 1Whitehead Institute for Biomedical Research, Cambridge, United States.
  • 2Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.
  • 3Department of Cell Biology, Harvard Medical School, Boston, United States.
  • 4Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States.
  • 5Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
  • 6Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
  • 7Department of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.

Abstract

Proteasomes are central regulators of protein homeostasis in eukaryotes. Proteasome function is vulnerable to environmental insults, cellular protein imbalance and targeted pharmaceuticals. Yet, mechanisms that cells deploy to counteract inhibition of this central regulator are little understood. To find such mechanisms, we reduced flux through the proteasome to the point of toxicity with specific inhibitors and performed genome-wide screens for mutations that allowed cells to survive. Counter to expectation, reducing expression of individual subunits of the proteasome's 19S regulatory complex increased survival. Strong 19S reduction was cytotoxic but modest reduction protected cells from inhibitors. Protection was accompanied by an increased ratio of 20S to 26S proteasomes, preservation of protein degradation capacity and reduced proteotoxic stress. While compromise of 19S function can have a fitness cost under basal conditions, it provided a powerful survival advantage when proteasome function was impaired. This means of rebalancing proteostasis is conserved from yeast to humans.

KEYWORDS:

HSF1; MG132; S. cerevisiae; bortezomib; cell biology; heat-shock; human; human biology; medicine; proteasome

PMID:
26327695
PMCID:
PMC4551903
DOI:
10.7554/eLife.08467
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
    Loading ...
    Support Center